Phosphate metabolism is an evolving area of basic and clinical research. In the past 15 years, knowledge on disturbances of phosphate homoeostasis has expanded, as has the discovery of new targeted therapies. Hypophosphataemia might be the biochemical finding in several diseases, and its clinical evaluation should initially focus on the assessment of pathophysiological mechanisms leading to low serum phosphate concentrations. Clinical consequences of hypophosphataemia can involve multiple organ systems and vary depending on several factors, the most important being the underlying disorder. This Review focuses on the approach to patients with hypophosphataemia and how underlying pathophysiological mechanisms should be understood in the evaluation of differential diagnosis. We define an algorithm for the assessment of hypophosphataemia and review the most up-to-date literature on specific therapies. Continuous research in this area will result in a better understanding and management of patients with hypophosphataemia.

Approach to patients with hypophosphataemia / Florenzano, P.; Cipriani, C.; Roszko, K. L.; Fukumoto, S.; Collins, M. T.; Minisola, S.; Pepe, J.. - In: THE LANCET DIABETES & ENDOCRINOLOGY. - ISSN 2213-8587. - 8:2(2020), pp. 163-174. [10.1016/S2213-8587(19)30426-7]

Approach to patients with hypophosphataemia

Cipriani C.
Secondo
;
Minisola S.;Pepe J.
Ultimo
2020

Abstract

Phosphate metabolism is an evolving area of basic and clinical research. In the past 15 years, knowledge on disturbances of phosphate homoeostasis has expanded, as has the discovery of new targeted therapies. Hypophosphataemia might be the biochemical finding in several diseases, and its clinical evaluation should initially focus on the assessment of pathophysiological mechanisms leading to low serum phosphate concentrations. Clinical consequences of hypophosphataemia can involve multiple organ systems and vary depending on several factors, the most important being the underlying disorder. This Review focuses on the approach to patients with hypophosphataemia and how underlying pathophysiological mechanisms should be understood in the evaluation of differential diagnosis. We define an algorithm for the assessment of hypophosphataemia and review the most up-to-date literature on specific therapies. Continuous research in this area will result in a better understanding and management of patients with hypophosphataemia.
2020
fibroblast growth factor-23; renal tubular dysfunction; clinical consequences; phosphate homeostasis; fibrous dysplasia; dietary phosphate; risk-factors; hearing-loss; vitamin-d; rickets
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Approach to patients with hypophosphataemia / Florenzano, P.; Cipriani, C.; Roszko, K. L.; Fukumoto, S.; Collins, M. T.; Minisola, S.; Pepe, J.. - In: THE LANCET DIABETES & ENDOCRINOLOGY. - ISSN 2213-8587. - 8:2(2020), pp. 163-174. [10.1016/S2213-8587(19)30426-7]
File allegati a questo prodotto
File Dimensione Formato  
Florenzano_Approach_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 457.05 kB
Formato Adobe PDF
457.05 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1400993
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 41
social impact